SCHEMBL6891056

SCHEMBL6891056

COC(=O)c1cccc2c1c1c(O)cc(C)cc1n2Cc1ccccc1Oc1ccccc1

nearest known ligand 0.42

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
TSPO P30536 2/20 0.42
KDM4E B2RXH2 1/20 0.38
HSD17B10 Q99714 1/20 0.38
PTGDR2 Q9Y5Y4 1/20 0.37
RAB9A P51151 1/20 0.36
IDO1 P14902 1/20 0.36
TDO2 P48775 1/20 0.36
MEN1 O00255 3/20 0.36
KMT2A Q03164 3/20 0.36
GAA P10253 1/20 0.36
TSHR P16473 1/20 0.36
LMNA P02545 1/20 0.36
MAPT P10636 1/20 0.36
TDP1 Q9NUW8 1/20 0.35
CD74 P04233 1/20 0.35
MIF P14174 1/20 0.35
FAAH O00519 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6771899 0.90 CTNNB1 (0.43) PTGDR2
SCHEMBL6895266 0.90 TSPO (0.42) TSPOKDM4EHSD17B10PTGDR2RAB9A
SCHEMBL6888939 0.90 TSPO (0.42) TSPOKDM4EHSD17B10RAB9AMEN1
SCHEMBL6889316 0.90 TSPO (0.47) TSPOKDM4EHSD17B10PTGDR2RAB9A
SCHEMBL6899176 0.88 TSPO (0.41) TSPOKDM4EHSD17B10RAB9AMEN1
SCHEMBL6896220 0.86 FAAH (0.43) KDM4EMEN1KMT2AGAALMNA
SCHEMBL6893122 0.86 CCR8 (0.40) TSPOPTGDR2KMT2AGAATDP1
SCHEMBL6892544 0.86 MAPT (0.44) KDM4EHSD17B10MEN1KMT2AGAA
SCHEMBL6888714 0.86 TSPO (0.39) TSPOLMNAMAPT
SCHEMBL6689196 0.85 GAA (0.47) KDM4EMEN1KMT2AGAATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6713645-B1 INHIBITING SPLA2 MEDIATED RELEASE OF FATTY ACIDS FOR TREATMENT OF CONDITIONS SUCH AS SEPTIC SHOCK ELI LILLY AND COMPANY 2004-03-30 US disclosed
US-6177440-B1 THERAPY FOR SEPSIS SHOCK; PHOSPHOLIPASE INHBITOR ELI LILLY AND COMPANY 2001-01-23 US disclosed
EP-0952149-A2 Substituted carbazoles, process for their preparation and their use as sPLA2 inhibitiors ELI LILLY AND COMPANY (US) 1999-10-27 EP disclosed